96732 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Cyclic peptides with only normal peptide bonds in the ring Tetrapeptides
COMPOSITIONS AND METHODS FOR DYE-BOUND CYCLIZED PEPTIDES FOR MEDICAL USE
#2SELF-ASSEMBLED CYCLIC PEPTIDE NANOTUBES FOR LIGHT ACTUATION
#3NOVEL MACROCYCLIC OPIOID PEPTIDES
#4Cyclic Tetrapeptides and Metal Complexes Thereof
#5Cyclic peptides multimers targeting α4β7 integrin
#6Proteasome inhibitors
#7PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES
#8COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS
#9INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#10CYCLIC TETRAPEPTIDE STEREOISOMERS
#11Cyclic peptides multimers targeting α-4-β-7 integrin
#12Proteasome inhibitors
#13ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#14Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
#15Rapaglutins, novel inhibitors of GLUT and use thereof
#16NOVEL MACROCYCLIC OPIOID PEPTIDES
#17Cyclic tetrapeptide analogs
#18Macrocyclic therapeutic agents, methods of manufacture, and methods of treatment
#19Cyclic peptides multimers targeting alpha-4-beta-7 integrin
#20Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
#21Macrocyclic peptides and derivatives thereof with opioid activity
#22Cyclic tetrapeptide stereoisomers
#23MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT
#24Novel Compounds
#25Cyclic peptide derivative, method for preparing same and composition thereof
#26MODULATION OF HEPATITIS B VIRUS CCCDNA TRANSCRIPTION
#27Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers
#28ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#29MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#30NMDA receptor modulators and prodrugs, salts, and uses thereof
#31Inhibitors of growth factor activation enzymes
#32MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#33Methods for synthesizing α4β7 peptide antagonists
#34SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES
#35Modulation of hepatitis B virus cccDNA transcription
#36CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PREPARING SAME AND COMPOSITION THEREOF
#37Cyclic tetrapeptide stereoisomers
#38Cyclic tetrapeptides and therapeutic applications thereof
#39Method for inhibiting ADAM proteases with cyclic peptides
#40MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT
#41Chemical reagents for attaching affinity molecules on surfaces
#42ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#43Methods and intermediates for preparing macrolactams
#44NMDA receptor modulators and prodrugs, salts, and uses thereof
#45Cyclic amino acid molecules and methods of preparing the same
#46Cyclic peptides as ADAM protease inhibitors
#47Modulation of hepatitis B virus CCCDNA transcription
#48Peptide increasing fusiogenic capacity of a gamete
#49Methods and intermediates for preparing macrolactams
#50Crystal forms of a HCV protease inhibitor
#51Process and intermediates for preparing macrolactams
#52Macrocycles and macrocycle stabilized peptides
#53CYCLIC TETRAPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF
#54CYCLOTETRAPEPTIDES WITH PRO-ANGIOGENIC PROPERTIES
#55Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#56Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
#57Mu opioid receptor agonist analogs of the endomorphins
#58Histone deacetylases, and uses related thereto
#59Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
#60Cyclic amino acid molecules and methods of preparing the same
#61Cyclic peptides with an anti-parasitic activity
#62Histone deacetylases, and uses related thereto
#63Histone deacetylases, and uses related thereto
#64Histone deacetylases, and uses related thereto
#65ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#66PROTEASE INHIBITION
#67HISTONE DEACETYLASES, AND USES RELATED THERETO
#68Cyclopeptide with Anti-Cancer Activity Derived from Collagen Type IV
#69Compound having histone deacetylase-inhibiting activity, and pharmaceutical composition comprising the compound as an active ingredient
#70Histone deacetylases, and uses related thereto
#71Means and Methods for Treating Advanced Stage Neuroblastoma
#72Imaging compounds, methods of making imaging compounds, methods of imaging, therapeutic compounds, methods of making therapeutic compounds, and methods of therapy
#73Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
#74CONJUGATES OF RGD PEPTIDES AND PORPHYRIN OR (BACTERIO) CHLOROHYLL PHOTOSYNTHESIZERS AND THEIR USES
#75Peptide based-compounds
#76Histone deacetylase inhibitor and process for producing the same
#77Histone deacetylases, and uses related thereto
#78Peptide increasing fusiogenic capacity of a gamete
#79Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
#80Cyclic tetrapeptide compound and use thereof
#81Heterocyclic inhibitors of IRES-mediated translation and methods of use thereof
#82Histone deacetylase inhibitors and methods for producing the same
#83Histogranin-like peptides, processes for their preparation and uses thereof
#84Carboxamide and amino derivatives and methods of their use
#85Carboxamide and amino derivatives and methods of their use
#86Anti-microbial peptides and compositions